Tag Archives: PantheRx Rare

Specialty Pharmacy News Roundup: February 2024

The latest specialty pharmacy news and insights. Stay up to date on industry and company trends with Specialty Pharmacy Database and client-specific research

PANTHERx Rare Selected by Aadi Bioscience as Exclusive Distributor for FYARRO™

PANTHERx Rare announced that it has been selected by Aadi Bioscience (Aadi) as the exclusive U.S. pharmacy distribution partner for new drug FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound)

PANTHERx Rare selected by Xeris Pharmaceuticals as Exclusive Distributor of Recorlev

PANTHERx Rare was recently selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for a new FDA-approved medication, Recorlev® (levoketoconazole).

PANTHERx and Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos

ChemoCentryx selected only Amber Specialty Pharmacy and PANTHERx as its limited distribution network for Tavenos